John MBA - Timber Pharmaceuticals CEO Chairman
| TMBRDelisted Stock | USD 1.72 0.01 0.58% |
Insider
John MBA is CEO Chairman of Timber Pharmaceuticals
| Age | 54 |
| Phone | 973 314 9577 |
| Web | https://www.timberpharma.com |
Timber Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (1.3727) % which means that it has lost $1.3727 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4324) %, meaning that it created substantial loss on money invested by shareholders. Timber Pharmaceuticals' management efficiency ratios could be used to measure how well Timber Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Timber Pharmaceuticals currently holds 331.15 K in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. Timber Pharmaceuticals has a current ratio of 2.4, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Timber Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Christine MBA | SAB Biotherapeutics | 68 | |
| Justin Trojanowski | Tempest Therapeutics | 36 | |
| Mark Newman | GeoVax Labs | 69 | |
| Steven Reich | Artelo Biosciences | 78 | |
| Philip Lee | Senti Biosciences | 42 | |
| Deborah Knobelman | Senti Biosciences | 50 | |
| CPA CPA | GeoVax Labs | 62 | |
| Denise Carter | Quoin Pharmaceuticals Ltd | 55 | |
| Wilson Wong | Senti Biosciences | N/A | |
| Petpiboon Prasit | Tempest Therapeutics | N/A | |
| Elizabeth Evans | Vaccinex | 51 | |
| Eddie Sullivan | SAB Biotherapeutics | 58 | |
| MBA CFA | Vaccinex | 50 | |
| McKee MD | GeoVax Labs | 72 | |
| RAC Sakai | Tempest Therapeutics | N/A | |
| Dr Dubensky | Tempest Therapeutics | 66 | |
| James Collins | Senti Biosciences | 58 | |
| II MD | Entera Bio | 71 | |
| Jeffrey PharmD | Nutriband | 54 | |
| Maurice Zauderer | Vaccinex | 78 | |
| Elif McDonald | Curis Inc | N/A | |
Management Performance
| Return On Equity | -3.43 | |||
| Return On Asset | -1.37 |
Timber Pharmaceuticals Management Team
Elected by the shareholders, the Timber Pharmaceuticals' board of directors comprises two types of representatives: Timber Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Timber. The board's role is to monitor Timber Pharmaceuticals' management team and ensure that shareholders' interests are well served. Timber Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Timber Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alan MD, Ex Officer | ||
| John MBA, CEO Chairman | ||
| Joseph Lucchese, CFO, VP |
Timber Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Timber Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.43 | |||
| Return On Asset | -1.37 | |||
| Current Valuation | (916.94 K) | |||
| Shares Outstanding | 3.43 M | |||
| Shares Owned By Insiders | 1.11 % | |||
| Shares Owned By Institutions | 7.78 % | |||
| Number Of Shares Shorted | 7.91 K | |||
| Price To Book | 6.94 X | |||
| Price To Sales | 17.19 X | |||
| Revenue | 83.18 K |
Pair Trading with Timber Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Timber Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Timber Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Timber Stock
Moving against Timber Stock
| 0.84 | EC | Ecopetrol SA ADR | PairCorr |
| 0.79 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.69 | HYMTF | Hyundai Motor | PairCorr |
| 0.69 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.65 | SHG | Shinhan Financial | PairCorr |
The ability to find closely correlated positions to Timber Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Timber Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Timber Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Timber Pharmaceuticals to buy it.
The correlation of Timber Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Timber Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Timber Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Timber Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |